Home Healthcare Medical Devices Endoluminal Suturing Devices Market

Endoluminal Suturing Devices Market Size, Share & Trends Analysis Report By Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery, Others), By End Use (Hospitals, Ambulatory Surgical Centres, Other) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Endoluminal Suturing Devices Market Size

The global endoluminal suturing devices market size was valued at USD 110.8 million in 2025 and is projected to grow from USD 122.62 million in 2026 to USD 275.94 million by 2034, registering a CAGR of 10.67% during the forecast period from 2026 to 2034. North America dominated the endoluminal suturing devices market with a market share of 39.5% in 2025.

Obesity is now a global pandemic that affects millions of people throughout the world, and bariatric endoscopies are becoming increasingly popular as a treatment option in healthcare settings. Suturing as well as stapling devices are most commonly utilised in the treatment of GERD and obesity. The main advantage of using these devices is that they allow for minimally invasive clinical treatments.

Clinical procedures as well as clinical trials have traditionally progressed at a slower rate than in recent years because to enormous improvements. Endoluminal suturing devices are frequently used in endoscopic procedures to implant thick sutures at the desired area with the aid of flexible sutures. a small, specialised suturing tool used during endoscopic surgery that is characterised by its pliability. Medical operations that use endoluminal suturing devices result in a better patient satisfaction, faster recovery time, reduced hospital visits, and shorter length of stay in medical facilities because of the desire for minimally invasive procedures. Advances in instrumentation have made endoluminal suturing devices more widely accepted.

Endoluminal Suturing Devices Market Size

Download a Free Sample To learn more about this report.

Application Insights

The global market is segmented into Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery, and Others. This segment accounted for nearly 37% of the total market share in 2021, making it the most dominant segment. In part, this is due to a rise in the number of gastrointestinal procedures and a wide variety of applications in the domain of gastroenterology. The pancreas, liver, biliary system, oropharynx, as well as alimentary canal are just some of the organs affected by this disease. More than 60.0 million Americans are diagnosed with a digestive disorder each year, as per the Gastroenterology Associates of Pensacola.

Gastroesophageal-reflux-disease (GERD) is one of the fastest-growing medical specialties, thanks to rising disease prevalence and advances in surgical technology. 8.9 million medical visits and an estimated yearly cost of USD 24.0 billion in 2017 were attributed to GERD, as per the Society of American Gastrointestinal & Endoscopic Surgeons. Aside from the fact that this condition is generally life-long, it is also linked to other health issues, such as esophageal stricture, adenocarcinoma, as well as esophagitis. Because endoluminal suturing is a popular treatment for this illness, the endoluminal suturing device market is likely to grow at a rapid pace over the forecast period.

As obesity rates rise and the number of bariatric surgery treatments rises, this market sector also has a sizable proportion. In addition to gastric bypass, sleeve, and balloon procedures, physicians now perform gastric revision, small gastric bypass, and endoscopic sleeve procedures. A total of 685,874 bariatric procedures were carried out in 2016, as per the International Federation for such Surgery of Obesity & Metabolic Disorder (IFSO). Endoluminal suturing devices are benefiting from an expanding bariatric surgery market as obesity rates rise and technology improves the effectiveness of various bariatric surgical methods.

Endoluminal Suturing Devices Market Size By Segments

Request Customizationto receive a tailored report.

End-Use Insights

The global market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. In 2021, hospitals accounted for over 70% of total market revenue, and this dominance is expected to persist over the forecast timeframe. Chronic disease and bariatric surgery are both increasing in prevalence. Endoluminal suturing devices are also benefiting from an expanding patient base and better healthcare infrastructure. There is also a growing demand for endoluminal suturing devices in developed nations like the US, where there are a large number of trained healthcare professionals.

Because of the increase in the proportion of minimally invasive procedures, the ambulatory surgical center market is expanding at the fastest rate. Endoluminal surgery advancements in technology are allowing more procedures to be performed as outpatient procedures. Because these surgical centers charge much less than hospitals do, patients and insurance companies alike can save a lot of money.

Endoluminal Suturing Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

In 2021, North America held a dominant position in the market for endoluminal suturing devices and was responsible for more than 45% of the revenue share. This is as a result of the availability of a sizable patient pool as well as advantageous reimbursement policies. It is anticipated that an increase in the number of bariatric procedures will have a direct and beneficial impact on the expansion of the marketplace for endoluminal-suturing-devices.

The American Society for Metabolic & Bariatric Surgery estimates that there were around 252,000 bariatric surgery operations performed in the United States in 2018, which represents a significant increase from the 158,000 treatments that were conducted in 2011.

North America Endoluminal Suturing Devices Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

The marketplace for endoluminal-suturing-devices is predicted to develop at the quickest pace in Asia Pacific owing to the existence of a vast population that is prone to a variety of chronic diseases and the presence of an improved healthcare infrastructure.

The prevalence of gastrointestinal diseases across the region is on the rise as a direct result of increasing urbanization, as well as a number of other environments as well as lifestyle factors that are undergoing significant shifts. In addition, developing countries like India and China are seeing significant demand for minimally-invasive-surgeries due to the rise of a variety of chronic and infectious disorders.

List of Key and Emerging Players in Endoluminal Suturing Devices Market

Braun Melsungen AG
Biolitec AG
Apollo Endosurgery, Inc
Medtronic Plc
Ethicon Endo-Surgery (Johnson and Johnson)
Medmasters - Janmed GmbH
Ovesco Endoscopy AG
Stryker Corporation
Covidien plc
UniTol Training Solutions
USGI Medical, Inc.
MeKo Laser Material Processing
Microchip Technology Inc.
Arthrex, Inc
L. Gore & Associates, Inc.

Key Industry Developments

June 2026
Boston Scientific continued strengthening its gastrointestinal endoscopy portfolio, including advanced endoscopic closure and suturing technologies used for minimally invasive gastrointestinal procedures. The company maintained focus on expanding therapeutic endoscopy solutions for defect closure, bariatric interventions, and complex GI procedures.
May 2026
Endoluminal suturing device manufacturers continued advancing next-generation endoscopic suturing platforms designed for gastrointestinal defect closure, endoscopic sleeve gastroplasty, fistula repair, leak closure, and stent fixation procedures. Market developments reflected increasing adoption of minimally invasive approaches across hospitals and ambulatory surgical centers.
March 2026
MedTech companies expanded investments in therapeutic endoscopy technologies, including flexible endoscopic systems and accessories that enable full-thickness suturing through natural orifice procedures. These innovations supported the shift toward incisionless and reduced-recovery surgical techniques.
January 2026
Healthcare providers continued increasing adoption of endoluminal suturing systems for bariatric procedures, gastrointestinal defect management, and post-surgical complication repair. Demand increased for devices offering improved precision, ease of deployment, and compatibility with advanced endoscopic platforms.

Report Scope

Segmentation

By Application 4
  • Bariatric Surgery
  • Gastrointestinal Surgery
  • Gastroesophageal Reflux Disease Surgery
  • Others
By End Use 3
  • Hospitals
  • Ambulatory Surgical Centres
  • Other

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Braun Melsungen AG · Biolitec AG · Apollo Endosurgery, Inc · Medtronic Plc · Ethicon Endo-Surgery (Johnson and Johnson)
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The endoluminal suturing devices market size is valued at USD 122.62 Million in 2026 and is projected to reach USD 275.94 Million by 2034, at a CAGR of 10.67% during the forecast period 2026-2034.
North America dominated the market with a share of 39.5% in 2025.
The leading players in this market are Braun Melsungen AG, Biolitec AG, Apollo Endosurgery, Inc, Medtronic Plc.
The endoluminal suturing devices market is projected to grow at a CAGR of 10.67% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now